The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Blood‐based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
Open accessAbstract
The last decade has seen a substantial increase in research focused on the identification of blood‐based biomarkers that have utility in Alzheimer's disease (AD). Blood‐based biomarkers have significant advantages of being time‐ and cost‐efficient as well as reduced invasiveness and increased patient acceptance. Despite these advantages and increased research efforts, the field has been hampered by lack of reproducibility and an unclear path for moving basic discovery toward clinical utilization. Here we reviewed the recent literature on blood‐based biomarkers in AD to provide a current state of the art. In addition, a collaborative model is proposed that leverages academic and industry strengths to facilitate the field in moving past discovery only work and toward clinical use. Key resources are provided. This new public‐private partnership model is intended to circumvent the traditional handoff model and provide a clear and useful paradigm for the advancement of biomarker science in AD and other neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · CHANCE · doi:10.1080/09332480.2005.10722754 · Cited by 4,702
Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Olsson, B., Lautner, R., Andreasson, U., Öhrfelt, A., Portelius, E., Bjerke, M., Hölttä, M., Rosén, C., Olsson, C., Strobel, G., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00070-3 · Cited by 2,049
Self-citationBelieve it or not: how much can we rely on published data on potential drug targets?
Prinz, F., Schlange, T., & Asadullah, K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439-c1 · Cited by 1,888 · cited 1×
“Current model of bio industry personnel) of published studies will not replicate in industrial laboratories [52].”
BackgroundPolicy: NIH plans to enhance reproducibility
Collins, F. S., & Tabak, L. A. (2014) · Nature · doi:10.1038/505612a · Cited by 1,247
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,043
2012 Alzheimer's disease facts and figures Alzheimer's Association ∗
Thies, W., & Bleiler, L. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.02.001 · Cited by 982
Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement
Lee, J. W., Devanarayan, V., Barrett, Y. C., Weiner, R., Allinson, J., Fountain, S., Keller, S., Weinryb, I., Green, M., Duan, L., et al. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-9045-3 · Cited by 768
Gisslén, M., Price, R. W., Andreasson, U., Norgren, N., Nilsson, S., Hagberg, L., Fuchs, D., Spudich, S., Blennow, K., & Zetterberg, H. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.036 · Cited by 481
Self-citationBacioglu, M., Maia, L. F., Preische, O., Schelle, J., Apel, A., Kaeser, S. A., Schweighauser, M., Eninger, T., Lambert, M., Pilotto, A., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.018 · Cited by 435
Plasma tau levels in Alzheimer's disease
Zetterberg, H., Wilson, D., Andreasson, U., Minthon, L., Blennow, K., Randall, J., & Hansson, O. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt163 · Cited by 387
Self-citationWinston, C. N., Goetzl, E. J., Akers, J. C., Carter, B. S., Rockenstein, E. M., Galasko, D., Masliah, E., & Rissman, R. A. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.04.001 · Cited by 379
Self-citationInnovative diagnostic tools for early detection of Alzheimer's disease
Laske, C., Sohrabi, H. R., Frost, S. M., López-de-Ipiña, K., Garrard, P., Buscema, M., Dauwels, J., Soekadar, S. R., Mueller, S., Linnemann, C., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.004 · Cited by 316
Self-citationThe future of blood‐based biomarkers for Alzheimer's disease
Henriksen, K., O'Bryant, S. E., Hampel, H., Trojanowski, J. Q., Montine, T. J., Jeromin, A., Blennow, K., Lönneborg, A., Wyss‐Coray, T., Soares, H., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.01.013 · Cited by 313
Self-citationO'Bryant, S. E., Gupta, V., Henriksen, K., Edwards, M., Jeromin, A., Lista, S., Bazenet, C., Soares, H., Lovestone, S., Hampel, H., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.08.099 · Cited by 290
Self-citationHansson, O., Zetterberg, H., Vanmechelen, E., Vanderstichele, H., Andreasson, U., Londos, E., Wallin, A., Minthon, L., & Blennow, K. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.027 · Cited by 281
Self-citationExosomes as new diagnostic tools in CNS diseases
Kanninen, K. M., Bister, N., Koistinaho, J., & Malm, T. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.020 · Cited by 218
Plasma proteins predict conversion to dementia from prodromal disease
Hye, A., Riddoch‐Contreras, J., Baird, A. L., Ashton, N. J., Bazenet, C., Leung, R., Westman, E., Simmons, A., Dobson, R., Sattlecker, M., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.05.1749 · Cited by 198
Kiddle, S. J., Sattlecker, M., Proitsi, P., Simmons, A., Westman, E., Bazenet, C., Nelson, S. K., Williams, S., Hodges, A., Johnston, C., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130380 · Cited by 189
Developing novel blood‐based biomarkers for Alzheimer's disease
Snyder, H. M., Carrillo, M. C., Grodstein, F., Henriksen, K., Jeromin, A., Lovestone, S., Mielke, M. M., O'Bryant, S., Sarasa, M., Sj⊘gren, M., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.10.007 · Cited by 177
Self-citationDiagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
Han, M., Nagele, E., DeMarshall, C., Acharya, N., & Nagele, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032383 · Cited by 176
Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum
Schneider, P., Hampel, H. J., & Büerger, K. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00104.x · Cited by 165
Self-citationDiagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
Nagele, E. P., Han, M. C., DeMarshall, C. A., Belinka, B. A., & Nagele, R. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023112 · Cited by 164
Exosomes in Alzheimer's disease
Malm, T., Loppi, S. H., & Kanninen, K. M. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.04.011 · Cited by 163
Casanova, R., Varma, S., Simpson, B., Kim, M., An, Y., Saldana, S., Riveros, C., Moscato, P., Griswold, M., Sonntag, D., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.008 · Cited by 162
Stern, R. A., Tripodis, Y., Baugh, C. M., Fritts, N. G., Martin, B. M., Chaisson, C., Cantu, R. C., Joyce, J. A., Shah, S., Ikezu, T., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-151028 · Cited by 155
Novel plasma biomarker surrogating cerebral amyloid deposition
KANEKO, N., Nakamura, A., Washimi, Y., Kato, T., Sakurai, T., Arahata, Y., Bundo, M., Takeda, A., Niida, S., Ito, K., et al. (2014) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.90.353 · Cited by 146
Blood and plasma-based proteomic biomarker research in Alzheimer's disease
Lista, S., Faltraco, F., Prvulovic, D., & Hampel, H. J. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.007 · Cited by 145
Self-citationDage, J. L., Wennberg, A. M. V., Airey, D. C., Hagen, C. E., Knopman, D. S., Machulda, M. M., Roberts, R. O., Jack, C. R., Petersen, R. C., & Mielke, M. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.001 · Cited by 145
Self-citationDrug discovery: new models for industry–academic partnerships
Tralau-Stewart, C. J., Wyatt, C. A., Kleyn, D., & Ayad, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.10.003 · Cited by 140
Plasma amyloid‐β and risk of Alzheimer's disease in the Framingham Heart Study
Chouraki, V. A., Beiser, A., Younkin, L. H., Preis, S. R., Weinstein, G., Hansson, O., Skoog, I. G., Lambert, J., Au, R., Launer, L. J., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.07.001 · Cited by 135
Burnham, S. C., Faux, N. G., Wilson, W. J., Laws, S. M., Ames, D. J., Bedő, J., Bush, A. I., Doecke, J. D., Ellis, K. A., Head, R. J., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.40 · Cited by 125
Self-citationSoares, H. D., Chen, Y., Sabbagh, M. N., Rohrer, A., Schrijvers, E. M. C., & Breteler, M. M. B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05066.x · Cited by 121
PRECISION MEDICINE - THE GOLDEN GATE FOR DETECTION, TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE
Hampel, H. J., O’Bryant, S. E., Castrillo, J. I., Ritchie, C. W., Rojkova, K., Broich, K., Benda, N., Nisticò, R., Frank, R., Dubois, B., et al. (2016) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2016.112 · Cited by 121
Self-citationBacioglu, M., Maia, L. F., Preische, O., Schelle, J., Apel, A., Kaeser, S. A., Schweighauser, M., Eninger, T., Lambert, M., Pilotto, A., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.07.007 · Cited by 116
Revolutionizing Alzheimer's disease and clinical trials through biomarkers
Mattsson, N., Carrillo, M. C., Dean, R. A., Devous, M. D., Nikolcheva, T., Pesini, P., Salter, H., Potter, W. Z., Sperling, R. A., Bateman, R. J., et al. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.09.001 · Cited by 113
Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer’s Disease
Tzen, K., Yang, S., Chen, T., Cheng, T.-W., Horng, H. E., Wen, H.-P., Huang, Y.-Y., Shiue, C., & Chiu, M. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500101j · Cited by 108
DeMarshall, C. A., Nagele, E. P., Sarkar, A., Acharya, N. K., Godsey, G. A., Goldwaser, E. L., Kosciuk, M. C., Thayasivam, U., Han, M. C., Belinka, B. A., et al. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.03.002 · Cited by 106
Andréasson, U., Blennow, K., & Zetterberg, H. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.05.005 · Cited by 104
Self-citationA blood screening test for Alzheimer's disease
O’Bryant, S. E., Edwards, M., Johnson, L. A., Hall, J. R., Villarreal, A. E., Britton, G. B., Quiceno, M. E., Cullum, C. M., & Graff‐Radford, N. R. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.06.004 · Cited by 102
Self-citationValidation of a Serum Screen for Alzheimer's Disease Across Assay Platforms, Species, and Tissues
O’Bryant, S. E., Xiao, G., Zhang, F., Edwards, M., German, D. C., Yin, X., Como, T., Reisch, J., Huebinger, R. M., Graff‐Radford, N. R., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141041 · Cited by 87
Self-citationPlasma Amyloid Beta-42 Independently Predicts Both Late-Onset Depression and Alzheimer Disease
Blasko, I., Kemmler, G., Jungwirth, S., Wichart, I., Krampla, W. W., Weissgram, S., Jellinger, K. A., Tragl, K. H., & Fischer, P. A. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181df48be · Cited by 79
Li, D.-N., Misialek, J. R., Boerwinkle, E., Gottesman, R., Sharrett, A., Mosley, T., Coresh, J., Wruck, L., Knopman, D., & Alonso, Á. (2016) · Alzheimer's & Dementia · doi:10.1016/j.dadm.2016.02.008 · Cited by 71
O’Bryant, S. E., Lista, S., Rissman, R. A., Edwards, M., Zhang, F., Hall, J. R., Zetterberg, H., Lovestone, S., Gupta, V. B., Graff‐Radford, N. R., et al. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.12.003 · Cited by 66
Self-citationWinterhoff, B. J. N., Freyer, L., Hammond, E., Giri, S., Mondal, S., Roy, D., Teoman, A., Mullany, S. A., Hoffmann, R., von Bismarck, A., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.02.007 · Cited by 65
Plasma sphingolipid changes with autopsy‐confirmed Lewy body or Alzheimer's pathology
Savica, R., Murray, M. E., Persson, X.-M. T., Kantarci, K., Parisi, J. E., Dickson, D. W., Petersen, R. C., Ferman, T. J., Boeve, B. F., & Mielke, M. M. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.02.005 · Cited by 59
Self-citationBlennow, K., Meyer, G. D., Hansson, O., Minthon, L., Wallin, A., Zetterberg, H., Lewczuk, P., Vanderstichele, H., Vanmechelen, E., Kornhuber, J., et al. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0059-0 · Cited by 58
Self-citationPlasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke
Weinstein, G., Beiser, A., Preis, S. R., Courchesne, P. L., Chouraki, V. A., Levy, D. A., & Seshadri, S. S. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.06.005 · Cited by 58
The Use of Biomarkers in Human Pharmacology (Phase I) Studies
Cohen, A. F., Burggraaf, J., van Gerven, J. M. A., Moerland, M., & Groeneveld, G. J. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135918 · Cited by 55
Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly
Westwood, S., Leoni, E., Hye, A., Lynham, S., Khondoker, M. R., Ashton, N. J., Kiddle, S. J., Baird, A. L., Sáinz‐Fuertes, R., Leung, R., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151155 · Cited by 51
Association of plasma and cortical amyloid beta is modulated by APOE ε4 status
Swaminathan, S., Risacher, S. L., Yoder, K. K., West, J. D., Shen, L., Kim, S., Inlow, M. H., Foroud, T., Jagust, W., Koeppe, R. A., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.01.007 · Cited by 49
DeMarshall, C. A., Han, M. C., Nagele, E. P., Sarkar, A., Acharya, N. K., Godsey, G. A., Goldwaser, E. L., Kosciuk, M. C., Thayasivam, U., Belinka, B. A., et al. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.09.010 · Cited by 47
Clemons, M. J., Cochrane, B., Pond, G. R., Califaretti, N., Chia, S., Dent, R. A., Song, X., Robidoux, A., Parpia, S., Warr, D. G., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3015-6 · Cited by 46
Plasma soluble neuregulin-1 as a diagnostic biomarker for Alzheimer's disease
Chang, K.-A., Shin, K. Y., Nam, E., Lee, Y., Moon, C., Suh, Y., & Lee, S. H. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.04.012 · Cited by 46
Gupta, V. B., Doecke, J. D., Hone, E., Pedrini, S., Laws, S. M., Thambisetty, M., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D. J., et al. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.12.001 · Cited by 45
Self-citationTranslational biomaterials — the journey from the bench to the market — think ‘product’
Serban, M. A. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.02.009 · Cited by 36
Gool, S. V., Kerschaver, E. V., Brock, P. R., Pottel, H., Hulstaert, F., Vanmechelen, E., Uyttebroeck, A., VOORDE, A. V. D., & Vanderstichele, H. (2000) · Leukemia · doi:10.1038/sj.leu.2401934 · Cited by 28
Self-citationBowsher, R. R., & Sailstad, J. M. (2008) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2008.09.026 · Cited by 24
Gool, S. V., Meyer, G. D., VOORDE, A. V. D., Vanmechelen, E., & Vanderstichele, H. (2004) · NeuroToxicology · doi:10.1016/j.neuro.2003.12.001 · Cited by 22
Self-citationVanderstichele, H., Shaw, L. M. J., Vandijck, M. L. J., Jeromin, A., Zetterberg, H., Blennow, K., Teunissen, C. E., & Engelborghs, S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.201830 · Cited by 22
Self-citationIntroduction to special issue on Advances in blood‐based biomarkers of Alzheimer's disease
O’Bryant, S. E. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.06.003 · Cited by 12
Self-citationScreening for Alzheimer’s Disease: Inspiration and Ideas From Breast Cancer Strategies
Lundquist, T. S., & Ready, R. E. (2013) · Journal of Applied Gerontology · doi:10.1177/0733464813500711 · Cited by 9
Cited by
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Nakamura, A., Kaneko, N., Villemagne, V. L., Kato, T., Doecke, J., Doré, V., Fowler, C., Li, Q.-X., Martins, R., Rowe, C., et al. (2018) · Nature · doi:10.1038/nature25456 · Cited by 1,681
Self-citationBlood-based biomarkers for Alzheimer's disease: towards clinical implementation
Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00361-6 · Cited by 1,045
Self-citationDiagnosis of Early Alzheimer's Disease: Clinical Practice in 2021
Porsteinsson, A. P., Isaacson, R. S., Knox, S., Sabbagh, M. N., & Rubino, I. (2021) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2021.23 · Cited by 744
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Hampel, H., O’Bryant, S. E., Molinuevo, J. L., Zetterberg, H., Masters, C. L., Lista, S., Kiddle, S. J., Batrla, R., & Blennow, K. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0079-7 · Cited by 716
Self-citationMielke, M. M., Hagen, C. E., Xu, J., Chai, X., Vemuri, P., Lowe, V. J., Airey, D. C., Knopman, D. S., Roberts, R. O., Machulda, M. M., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.013 · Cited by 621
Self-citation
Metadata
- Authors
- O'Bryant, S. E., Mielke, M. M., Rissman, R. A., Lista, S., Vanderstichele, H., Zetterberg, H., Lewczuk, P., Posner, H., Hall, J., Johnson, L., Fong, Y., Luthman, J., Jeromin, A., Batrla‐Utermann, R., Villarreal, A., Britton, G., Snyder, P. J., Henriksen, K., Grammas, P., Gupta, V., Martins, R., Hampel, H., & Area, B. B. B. P. I.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2016-11-18
- Volume
- 13
- Issue
- 1
- Pages
- 45-58
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2550934658
- Cited by
- 303
- References
- 65
- FWCI
- 28.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.